Correlation between antimicrobial consumption and resistance among Staphylococcus aureus and enterococci causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2009

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 30, Issue 2, 2011, Pages 265-271

  Lai, C C ^a   Wang, C Y ^b   Chu, C C ^c   Tan, C K ^a   Lu, C L ^c   Lee, Y L ^c   Huang, Y T ^c   Lee, P I ^c   Hsueh, P R ^d  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b CARDINAL TIEN HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOTAXIME; CEFPIROME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; ERTAPENEM; FUSIDIC ACID; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TEICOPLANIN; TIMENTIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DRUG USE; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRESCRIPTION; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; TAIWAN; TREND STUDY; UNIVERSITY HOSPITAL; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; ENTEROCOCCUS; GLYCOPEPTIDES; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; STAPHYLOCOCCUS AUREUS; TAIWAN; TEICOPLANIN; VANCOMYCIN;

EID: 78751567822     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-010-1081-1     Document Type: Article

References (22)

1. C Buke L Armand-Lefevre I Lolom W Guerinot C Deblangy R Ruimy A Andremont JC Lucet 2007 Epidemiology of multidrug-resistant bacteria in patients with long hospital stays Infect Control Hosp Epidemiol 28 1255 1260 10.1086/522678 17926276 (Pubitemid 47596564)
2. AC Gales RN Jones SS Andrade HS Sader 2005 Antimicrobial susceptibility patterns of unusual nonfermentative gram-negative bacilli isolated from Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2002) Mem Inst Oswaldo Cruz 100 571 577 1:CAS:528:DC%2BD2MXht12qtbvK 10.1590/S0074-02762005000600011 16302068
3. AI Hidron JR Edwards J Patel TC Horan DM Sievert DA Pollock SK Fridkin National Healthcare Safety Network Team Participating National Healthcare Safety Network Facilities 2008 NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007 Infect Control Hosp Epidemiol 29 996 1011 10.1086/591861 18947320
4. B Ruttimanns Keck C Hartmeier A Maetzel HC Bucher 2004 Long-term antibiotic cost saving from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital Clin Infect Dis 38 348 356 10.1086/380964 (Pubitemid 38200110)
5. PR Hsueh WH Chen LJ Teng KT Luh 2005 Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci at a university hospital in Taiwan from 1991 to 2003: resistance trends, antibiotic usage and in vitro activities of newer antimicrobial agents Int J Antimicrob Agents 26 43 49 1:CAS:528:DC%2BD2MXlvVWlurg%3D 10.1016/j.ijantimicag. 2005.04.007 15975769 (Pubitemid 40854115)
6. PR Hsueh WH Chen KT Luh 2005 Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infection from 1991-2003 at a university hospital in Taiwan Int J Antimicrob Agent 26 463 472 1:CAS:528:DC%2BD2MXht1egtrvO 10.1016/j.ijantimicag.2005.08.016 (Pubitemid 41635496)
7. S Metz-Gercek A Maieron R Straub P Wieninger P Apfalter H Mittermayer 2009 Ten years of antibiotic consumption in ambulatory care: trends in prescribing practice and antibiotic resistance in Austria BMC Infect Dis 9 61 10.1186/1471-2334-9-61 19439064
8. PP Cook PG Catrou JD Christie PD Young RE Polk 2004 Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram J Antimicrob Chemother 53 853 859 1:CAS:528:DC%2BD2cXjs1Wqtr4%3D 10.1093/jac/dkh163 15044426 (Pubitemid 38660291)
9. E Meyer F Schwab P Gastmeier H Rueden FD Daschner 2006 Surveillance of antimicrobial use and antimicrobial resistance in German intensive care units (SARI): a summary of the data from 2001 through 2004 Infect 34 303 309 1:CAS:528:DC%2BD2sXht1art78%3D 10.1007/s15010-006-6619-x (Pubitemid 46001355)
10. AH Mutnick PR Rhomberg HS Sader RN Jones 2004 Antimicrobial usage and resistance trend relationship from MYSTIC programme in North America J Antimicrob Chemother 53 290 296 1:CAS:528:DC%2BD2cXos1aqsQ%3D%3D 10.1093/jac/dkh039 14711839 (Pubitemid 38239964)
11. NS Crowcroft O Ronveaux DL Monnet R Mertens 1999 Methicillin-resistant Staphylococcus aureus and antimicrobial use in Belgian hospitals Infect Control Hosp Epidemiol 20 31 36 1:STN:280:DyaK1M7isVCmsQ%3D%3D 10.1086/501555 9927263
12. EM Graffunder RA Venezia 2002 Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials J Antimicrob Chemother 49 999 1005 1:CAS:528: DC%2BD38XltVyrtr8%3D 10.1093/jac/dkf009 12039892
13. DL Monnet 1998 Methicillin-resistant Staphylococcus aureus and its relationship to antimicrobial use: possible implications for control Infect Control Hosp Epidemiol 19 552 559 1:STN:280:DyaK1cvivFShsw%3D%3D 10.1086/647872 9758054
14. AA Muller F Mauny M Bertin C Cornette JM Lopez-Lozano JF Viel DR Talon X Bertrand 2003 Relationship between spread of methicillin-resistant Staphylococcus aureus and antimicrobial use in a French university hospital Clin Infect Dis 36 971 978 10.1086/374221 12684908 (Pubitemid 36513280)
15. RA Dahms EM Johnson CL Statz JT Lee DL Dunn GJ Beilman 1998 Third-generation cephalosporins and vancomycin as risk factors for post operative vancomycin-resistant Enterococcus infection Arch Surg 133 1343 1346 1:CAS:528:DyaK1MXhsFSnug%3D%3D 10.1001/archsurg.133.12.1343 9865653 (Pubitemid 29001298)
16. H Harbarth S Cosgrove Y Carmeli 2002 Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci Antimicrob Agents Chemother 46 1619 1628 1:CAS:528:DC%2BD38XktFCnu78%3D 10.1128/AAC.46.6.1619-1628.2002 12019066 (Pubitemid 34535173)
17. LB Rice R Hutton-Thomas V Lakticova MS Helfand CJ Donskey 2004 β-Lactam antibiotics and gastrointestinal colonization with vancomycin-resistant enterococci Clin Infect Dis 189 1113 1118 1:CAS:528:DC%2BD2cXjtF2mtLk%3D
18. RA Venezia BE Domaracki AM Evans KE Preston EM Graffunder 2001 Selection of high-level oxacillin resistance in heteroresistant Staphylococcus aureus by fluoroquinolone exposure J Antimicrob Chemother 48 375 381 1:CAS:528: DC%2BD3MXntlSgtLk%3D 10.1093/jac/48.3.375 11533002
19. JS Garner WR Jarvis TG Emori TC Horan JM Hughes 1988 CDC definitions for nosocomial infections, 1988 Am J Infect Control 16 128 40 1:STN:280: DyaL1czgvVSnug%3D%3D 10.1016/0196-6553(88)90053-3 2841893
20. Clinical and Laboratory Standards Institute (2009) Performance standards for antimicrobial susceptibility testing; Nineteenth informational supplement (M100-S19). CLSI, Wayne
21. Clinical and Laboratory Standards Institute (2006) Performance standards for antimicrobial disk susceptibility tests: approved standard. Document M2-A9, 9th edn. CLSI, Wayne
22. LD Liebowitz MC Blunt 2008 Modification in prescribing practices for third-generation cephalosporins and ciprofloxacin is associated with a reduction in methicillin-resistant Staphylococcus aureus bacteraemia rate J Hosp Infect. 69 328 36 1:STN:280:DC%2BD1cvnvVWrug%3D%3D 10.1016/j.jhin.2008.04.026 18602189